Cannabinoids For Treatment Of Spasticity And Other Symptoms Related To Multiple Sclerosis (CAMS Study): Multicentre Randomised Placebo-controlled Trial
Notes for this study:
|Number of Subjects
In persons with multiple sclerosis given either pure THC or cannabis extracts over 15 weeks, supplementation failed to result in any improvements in physician-assessed physical mobility although patient-reported stiffness, pain, spasticity, and spasms (but not shake/tremor) appeared to be improved with supplementation. This led to improvements in sleep quality, although symptoms of fatigue and depression were unaffected.